[Skip to Content]
[Skip to Content Landing]
Views 217
Citations 0
December 5, 2012

Clarification of Conflict of Interest Disclosures

Author Affiliations

Letters Section Editor: Jody W. Zylke, MD, Senior Editor.

Author Affiliation: Stefan P. Kruszewski M. D. & Associates, Harrisburg, Pennsylvania (skruszewski@spkmd.com).

JAMA. 2012;308(21):2186-2187. doi:10.1001/jama.2012.71214

To the Editor: In a Viewpoint on preventing depression,1 Dr Reynolds reported the following disclosures: “Dr Reynolds reports receiving pharmaceuticals for research studies from Bristol-Myers Squibb, Forest, Pfizer, and Lilly.” Subsequently, after notification that he had submitted incomplete conflict of interest (COI) disclosures, Reynolds amended his disclosures, adding government and private funding sources, and indicating “a misunderstanding of the requirements for reporting of conflicts of interest.”2

First Page Preview View Large
First page PDF preview
First page PDF preview